All Stories

  1. Advances and Challenges of Biodegradable Implant Materials with a Focus on Magnesium-Alloys and Bacterial Infections
  2. Prospects of magnesium alloys to manufacture disappearing and antibacterial medical implants
  3. Advances and Challenges of Biodegradable Implant Materials with a Focus on Magnesium-Alloys and Bacterial Infections
  4. Advances and Challenges of Biodegradable Implant Materials with a Focus on Magnesium-Alloys and Bacterial Infections
  5. Multivalent Siderophore-DOTAM Conjugates as Theranostics for Imaging and Treatment of Bacterial Infections
  6. Differential magnesium implant corrosion coat formation and contribution to bone bonding
  7. Phosphate conversion coating reduces the degradation rate and suppresses side effects of metallic magnesium implants in an animal model
  8. Evaluation of the inflammatory potential of implant materials in a mouse model by bioluminescent imaging of intravenously injected bone marrow cells
  9. Susceptibility of metallic magnesium implants to bacterial biofilm infections
  10. ANTIBACTERIAL ACTIVITY OF MAGNESIUM
  11. Magnesium-containing layered double hydroxides as orthopaedic implant coating materials-Anin vitroandin vivostudy
  12. Identification of whole pathogenic cells by monoclonal antibodies generated against a specific peptide from an immunogenic cell wall protein
  13. Highly biocompatible behaviour and slow degradation of a LDH (layered double hydroxide)-coating on implants in the middle ear of rabbits
  14. Animal Test Models for Implant-Associated Inflammation and Infections
  15. Controlled drug release from antibiotic-loaded layered double hydroxide coatings on porous titanium implants in a mouse model
  16. Nanoporous Silica Coatings as a Drug Delivery System for Ciprofloxacin
  17. The formation of an organic coat and the release of corrosion microparticles from metallic magnesium implants
  18. Blood Coagulation and Fibrinolysis
  19. Evaluation and comparison of in vitro and in vivo degradation kinetics of magnesium
  20. In vivo testing of a bioabsorbable magnesium alloy serving as total ossicular replacement prostheses
  21. Mesoporous silica films as a novel biomaterial: applications in the middle ear
  22. Assessment of cellular reactions to magnesium as implant 
material in comparison to titanium and to glyconate using 
the mouse tail model
  23. Efficacy of nanoporous silica coatings on middle ear prostheses as a delivery system for antibiotics: An animal study in rabbits
  24. Involvement of the mitogen activated protein kinase Hog1p in the response of Candida albicans to iron availability
  25. Fluoride and calcium-phosphate coated sponges of the magnesium alloy AX30 as bone grafts: a comparative study in rabbits
  26. Layered double hydroxides as efficient drug delivery system of ciprofloxacin in the middle ear: an animal study in rabbits
  27. Evaluation of single-cell force spectroscopy and fluorescence microscopy to determine cell interactions with femtosecond-laser microstructured titanium surfaces
  28. Comparison of in vitro and in vivo protein release from hydrogel systems
  29. Histological and molecular evaluation of iron as degradable medical implant material in a murine animal model
  30. Functional inhibition of transitory proteins by intrabody-mediated retention in the endoplasmatic reticulum
  31. Directing neuronal cell growth on implant material surfaces by microstructuring
  32. A novel functional assay for fungal histidine kinases group III reveals the role of HAMP domains for fungicide sensitivity
  33. Amino-modified silica surfaces efficiently immobilize bone morphogenetic protein 2 (BMP2) for medical purposes
  34. Mesoporous silica coatings for controlled release of the antibiotic ciprofloxacin from implants
  35. A novel biological compound could be useful for controled release of antibiotics
  36. Immobilization of alkaline phosphatase on modified silica coatings
  37. Common signatures for gene expression in postnatal patients with patent arterial ducts and stented arteries
  38. Experimental middle ear surgery in rabbits: a new approach for reconstructing the ossicular chain
  39. A biomechanical ear model to evaluate middle-ear reconstruction
  40. Free Bioverit (R) II Implants Coated with a Nanoporous Silica Layer in a Mouse Ear Model -- A Histological Study
  41. Differential fine-tuning of cochlear implant material-cell interactions by femtosecond laser microstructuring
  42. Differential fine-tuning of cochlear implant material-cell interactions by femtosecond laser microstructuring
  43. Normative data of multifrequency tympanometry in rabbits
  44. Cartilage repair on magnesium scaffolds used as a subchondral bone replacement
  45. Control of smooth muscle cell proliferation by ferrous iron
  46. The mouse immune system is apparently not dependent on the hypothetical gene NRF1
  47. Establishment of murine cell lines by constitutive and conditional immortalization
  48. Transformation of mouse fibroblasts alters the induction pattern of type I IFNs after virus infection
  49. Corrigendum to “Novel highly efficient intrabody mediates complete inhibition of cell surface expression of the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR)” [Journal of Immunological Methods 300 (2005) 146–159]
  50. Novel highly efficient intrabody mediates complete inhibition of cell surface expression of the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR)
  51. Transcriptionally regulated immortalization overcomes side effects of temperature-sensitive SV40 large T antigen
  52. Application of a Reversible Immortalization System for the Generation of Proliferation-Controlled Cell Lines
  53. Nucleolar localization and mobility analysis of the NF- B repressing factor NRF
  54. Coordination of cell growth in cocultures by a genetic proliferation control system
  55. Review: Activities of IRF-1
  56. Enhanced productivity during controlled proliferation of BHK cells in continuously perfused bioreactors
  57. Recombinant glycoprotein product quality in proliferation-controlled BHK-21 cells
  58. Genetic optimization of recombinant glycoprotein production by mammalian cells
  59. A Ribosomal Protein Is Required for Translational Regulation of GCN4 mRNA. EVIDENCE FOR INVOLVEMENT OF THE RIBOSOME IN eIF2 RECYCLING
  60. Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrant
  61. The Position Dependence of Translational Regulation via RNA-RNA and RNA-Protein Interactions in the 5'-Untranslated Region of Eukaryotic mRNA Is a Function of the Thermodynamic Competence of 40 S Ribosomes in Translational Initiation
  62. Mutants of Eukaryotic Initiation Factor eIF-4E with Altered mRNA Cap Binding Specificity Reprogram mRNA Selection by Ribosomes in Saccharomyces cerevisiae
  63. Regulation of the ADE2 gene from Saccharomyces cerevisiae
  64. Autoregulation of the yeast lysyl-tRNA synthetase gene GCD5/KRS1 by translational and transcriptional control mechanisms
  65. Translation and regulation of translation in the yeast Saccharomyces cerevisiae
  66. Genetic localization of the Saccharomyces cerevisiae genes tif1 and tif2
  67. Evidence for regulation of reinitiation in translational control of GCN4 mRNA.
  68. The positive regulatory function of the 5'-proximal open reading frames in GCN4 mRNA can be mimicked by heterologous, short coding sequences.
  69. A segment of GCN4 mRNA containing the upstream AUG codons confers translational control upon a heterologous yeast transcript.
  70. Multiple upstream AUG codons mediate translational control of GCN4
  71. Primary structure of wild-type and mutant alleles of the PET494 gene of Saccharomyces cerevisiae
  72. A nuclear mutation that post-transcriptionally blocks accumulation of a yeast mitochondrial gene product can be suppressed by a mitochondrial gene rearrangement
  73. Molecular cloning and genetic mapping of the PET494 gene of Saccharomyces cerevisiae